BioLineRx Ltd. Research and Development Expense
BioLineRx Ltd. (BLRX) reported Research and Development Expense of $8.09 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-23
- BioLineRx Ltd. research and development expense for the quarter ending 2025-06-30 was $2.33M, a 4.54% increase year-over-year.
- BioLineRx Ltd. research and development expense for the quarter ending 2024-06-30 was $2.23M, a 25.98% decline year-over-year.
- BioLineRx Ltd. research and development expense for the quarter ending 2023-06-30 was $3.01M, a 44.28% decline year-over-year.
- BioLineRx Ltd. research and development expense for the quarter ending 2022-06-30 was $5.39M, a 4.98% increase year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $8.09M 20-F · filed 2026-03-23 | ||
| 2025-06-30 | $2.33M 6-K · filed 2025-08-14 | $3.95M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $9.15M 20-F · filed 2026-03-23 | ||
| 2024-06-30 | $2.23M 6-K · filed 2025-08-14 | $4.72M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $12.52M 20-F · filed 2026-03-23 | ||
| 2023-06-30 | $3.01M 6-K · filed 2024-08-15 | $6.69M 6-K · filed 2024-08-15 | |
| 2022-12-31 | $17.63M 20-F · filed 2025-03-31 | ||
| 2022-06-30 | $5.39M 6-K · filed 2023-08-30 | $9.83M 6-K · filed 2023-08-30 | |
| 2021-12-31 | $19.47M 20-F · filed 2024-03-26 | ||
| 2021-06-30 | $5.14M 6-K · filed 2022-08-16 | $9.42M 6-K · filed 2022-08-16 | |
| 2020-12-31 | $18.17M 20-F · filed 2023-03-22 | ||
| 2020-06-30 | $4.64M 6-K · filed 2021-08-18 | $10.06M 6-K · filed 2021-08-18 | |
| 2019-12-31 | $23.44M 20-F · filed 2022-03-16 | ||
| 2019-06-30 | $5.30M 6-K · filed 2020-08-06 | $9.69M 6-K · filed 2020-08-06 | |
| 2018-12-31 | $19.81M 20-F · filed 2021-02-23 | ||
| 2018-06-30 | $4.48M 6-K · filed 2019-08-06 | $9.55M 6-K · filed 2019-08-06 | |
| 2017-12-31 | $19.51M 20-F · filed 2020-03-12 | ||
| 2017-06-30 | $4.06M 6-K · filed 2018-08-13 | $7.65M 6-K · filed 2018-08-13 | |
| 2016-12-31 | $11.18M 20-F · filed 2019-03-28 | ||
| 2015-12-31 | $11.49M 20-F · filed 2018-03-06 |